Clinical Trials
7 trialsNCT07005102 2026-06-05
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
AbbVie
Phase 2/3 Recruiting
NCT07324577 2026-05-22
RELAX
Wake Forest University Health Sciences
Phase NA Recruiting
NCT05733091 2026-04-21
Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
M.D. Anderson Cancer Center
Recruiting
NCT05059678 2026-02-19
Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT05427240 2026-01-16
eReach2
Abramson Cancer Center at Penn Medicine
Phase NA Recruiting
NCT07183527 2025-09-19
CARES
University of Pittsburgh
Phase NA Recruiting
NCT03257969 2025-03-05
DROP-SFPO
Hospices Civils de Lyon
Phase NA Recruiting